Company Filing History:
4 out of 158 
1 out of 160 
1 out of 4 Years Active: 2001-2025
Title: **Karola Rittner: Innovating Cancer Therapy through Oncolytic Virus Technology**
Introduction
Karola Rittner, an accomplished inventor based in Strasbourg, France, has made significant contributions to the field of cancer research. With a portfolio of four patents, Rittner is recognized for pioneering innovative therapies utilizing oncolytic viruses. His inventions reflect a deep commitment to advancing medical science and addressing challenges posed by proliferative diseases, particularly cancers.
Latest Patents
Among his most notable patents is the development of an oncolytic virus designed for the expression of immune checkpoint modulators. This groundbreaking invention outlines a virus that incorporates nucleotide sequences encoding one or more immune checkpoint modulators. Additionally, it includes a pharmaceutical composition comprising an effective amount of this oncolytic virus, potentially paired with a pharmaceutically acceptable vehicle. The application of this invention holds promise for treating various proliferative diseases, offering new hope for cancer therapies.
Career Highlights
Karola Rittner has worked with esteemed organizations, including Transgene S.A. and Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His work at these institutions has enabled him to focus on innovative approaches to cancer treatment, pushing the boundaries of what is possible in medicinal science and technology. Rittner's dedication to research has undoubtedly established him as a prominent figure in the field of oncology.
Collaborations
Throughout his career, Rittner has collaborated with notable professionals, including Nathalie Silvestre and Michel Geist. These partnerships have facilitated the exchange of knowledge and ideas, further enriching his inventive endeavors. Together, they have strived to propel advancements in cancer research, highlighting the importance of collaboration in scientific innovation.
Conclusion
Karola Rittner stands as a testament to the power of innovation in combating cancer through his pioneering development of oncolytic virus technology. His patents not only demonstrate his ingenuity but also his commitment to improving patient outcomes. As research in this field progresses, Rittner’s contributions will likely continue to influence the future of cancer treatment, underscoring the vital role that inventors play in the advancement of medicine.